Toxicity to healthy cells limits the usefulness of conventional chemotherapeutic agents. These drugs kill rapidly dividing cells of all types, not just those in a tumor. In addition to dividing rapidly, some cancer cells establish metastases that have a different stiffness than the surrounding tissue. This mechanical property of a cellular microenvironment is referred to … Read moreLeveraging Cellular Mechanical Signaling to Improve Drug Specificity
From Osteoporosis to Breast Cancer Denosumab, a biologic agent, and bisphosphonates, which are small molecule drugs, reduce fractures that are complications of osteoporosis, including those caused by breast cancer hormone therapies that block estrogen signaling, menopause, or surgically-induced menopause (oophorectomy with or without hysterectomy). Both denosumab and bisphosphonates also reduce the risk of bone metastasis … Read moreCan Denosumab Prevent Breast Cancer?